Evidence map›Paper›PMID 24800231›Full record

ArticleBioMed research international2014

Preliminary in vitro and in vivo evaluation of antidiabetic activity of Ducrosia anethifolia Boiss. and its linear furanocoumarins.

Nagwa M M Shalaby, Howaida I Abd-Alla, Hanan F Aly, Marzougah A Albalawy, Kamel H Shaker, Jalloul Bouajila

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Inhibition of the polyol pathway byFrontiers in pharmacology · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Heliyon · 2021
    Article
  10. Review
  11. BioMed research international · 2021
    Article
  12. Pharmaceuticals (Basel, Switzerland) · 2020
    Article
  13. Pharmaceuticals (Basel, Switzerland) · 2020
    Review
  14. Article
  15. Promising selective MAO-B inhibition by sesamin, a lignan fromSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Nagwa M M ShalabyNatural Compounds Chemistry Department, National Research Centre, Dokki, Giza 12622, Egypt.
Howaida I Abd-AllaNatural Compounds Chemistry Department, National Research Centre, Dokki, Giza 12622, Egypt.
Hanan F AlyTherapeutic Chemistry Department, National Research Centre, Dokki, Giza 12622, Egypt.
Marzougah A AlbalawyUniversity of Tabuk, Tabuk 71491, Saudi Arabia.
Kamel H ShakerNatural Compounds Chemistry Department, National Research Centre, Dokki, Giza 12622, Egypt ; Chemistry Department, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia.
Jalloul BouajilaFaculté de Pharmacie de Toulouse, Laboratoire des IMRCP UMR CNRS 5623, Université de Toulouse, Université Paul-Sabatier, 118 Route de Narbonne, 31062 Toulouse, France.
National Research Centre · EGKing Khalid University · SASoftmat - Chimie des colloïdes, polymères & assemblages complexes · FRUniversity of Tabuk · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim. Ducrosia anethifolia is used as flavoring additive. There have been little detailed phytochemical reports on this genus and the antidiabetic activity of this plant is not yet evaluated. Method. Structure of compounds was deduced by spectroscopic analyses. Preliminary in vitro evaluation of the antidiabetic activity of crude extract and its furanocoumarins was carried out ( α -amylase, α -glucosidase, and β -galactosidase). The in vivo activity was investigated by measuring some oxidative stress markers. Biomarkers of liver injury and kidney were also determined. Results. Eight linear furanocoumarins, psoralen, 5-methoxypsoralen, 8-methoxypsoralen, imperatorin, isooxypeucedanin, pabulenol, oxypeucedanin methanolate, oxypeucedanin hydrate, and 3-O-glucopyranosyl- β -sitosterol, were isolated. All compounds were reported for the first time from the genus Ducrosia except pabulenol. The blood glucose level, liver function enzymes, total protein, lipid, and cholesterol levels were significantly normalized by extract treatment. The antioxidant markers, glucolytic, and gluconeogenic enzymes were significantly ameliorated and the elevated level of kidney biomarkers in the diabetic groups was restored. The compounds showed inhibitory activity in a concentration dependant manner. Imperatorin and 5-methoxypsoralen showed the most potent inhibiting power. Conclusion. D. anethifolia extract showed hypoglycemic, hypolipidemic, and antioxidant effect as well as ameliorating kidney function. This extract and some linear furanocoumarins exhibited carbohydrate metabolizing enzymes inhibitory effect.

Indexed as

AnimalsApiaceaeBlood GlucoseDiabetes Mellitus, ExperimentalDose-Response Relationship, DrugFood AdditivesFurocoumarinsHypoglycemic AgentsMalePilot ProjectsPlant ExtractsRatsRats, WistarSpecies SpecificityTreatment OutcomeBlood GlucoseFood AdditivesFurocoumarinsHypoglycemic AgentsPlant Extracts

Identifiers

PMID24800231
PMCPMC3988972
OpenAlexW1966133180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.